Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus

Bone Marrow Transplantation

Volumn 27, Issue 6, 2001, Pages 647-652

  Grazziutti, M ^a,b   Przepiorka, D ^c   Rex, J H ^b   Braunschweig, I ^a   Vadhan Raj, S ^a   Savary, C A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Aspergillus; Candida; Dendritic cell; Fungi; Immune reconstitution

Indexed keywords

B7 ANTIGEN; CD34 ANTIGEN; CD86 ANTIGEN; FUNGUS ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12;

ALLOTRANSPLANTATION; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; AUTOTRANSPLANTATION; CELL COUNT; CELLULAR IMMUNITY; CONIDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPOSURE; FLUORESCENCE; FUNGUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STEM CELL; VOLUNTEER;

ASPERGILLUS FUMIGATUS; CYTOKINES; DENDRITIC CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHAGOCYTOSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035037216     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702832     Document Type: Article

References (24)

1. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
2. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
3. Aspergillosis in bone marrow transplant recipients
4. Cytokine- and T-helper dependent lung mucosa immunity in mice with invasive pulmonary aspergillosis
5. T cell vaccination in mice with invasive pulmonary aspergillosis
6. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients
7. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation
8. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
9. Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed system
10. Proliferating dendritic cell progenitors in human blood
11. Efficient presentation of soluble antigen by cultured human dendritic cells is mantained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
12. Aspergillus fumigatus conidia induce a Th1-type cytokine response
13. Activated lymphocytes reduce adherence of Aspergillus fumigatus
14. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients
15. Early recovery of lymphocyte response to Candida after bone marrow transplantation in colonized patients
16. Th1 and Th2 cytokines in mice with invasive aspergillosis
17. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses
18. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecule in the major histocompatibility complex II compartment: Downregulation by cytokines and bacterial products
19. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo
20. Immunosuppression in vitro by a metabolite of a human pathogenic fungus
21. Propogation and culture of dendritic cells
22. Ligation of CD40 on dendritic cells triggers production of high levels of Interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
23. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin-12 by dendritic cells and their redistribution to T cell areas
24. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients